Resumen

TOBON T, Manuela et al. Adalimumab-induced cutaneous lupus. Rev.Colomb.Reumatol. [online]. 2016, vol.23, n.4, pp.271-274. ISSN 0121-8123.  https://doi.org/10.10167j.rcreu.2016.10.001.

Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.

Palabras clave : Adalimumab; Cutaneous lupus erythematosus; Rheumatoid arthritis.

        · resumen en Español     · texto en Español     · Español ( pdf )